Literature DB >> 16103636

Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.

Giovanni Carlo Del Vecchio1, Lucia Giordani, Attilio De Santis, Domenico De Mattia.   

Abstract

Hematopoiesis is a complex process regulated by nuclear proteins that coordinate lineage-specific patterns of gene expression. Targeted mutagenesis has revealed critical roles for the X-linked transcription factor GATA-1 in erythrocyte and megakaryocyte differentiation. GATA-1 has two zinc fingers essential for normal function. The C-terminal finger is necessary for DNA binding. The N-terminal finger mediates interaction with FOG-1, a cofactor for GATA-1. Mutations in the N-terminal zinc finger of GATA-1 result in abnormal hematopoiesis. Here we report a family with a novel single base mutation that results in an amino acid substitution (Gly208Arg) within the highly conserved portion of the GATA-1 N-terminal finger domain, leading to dyserythropoietic anemia and macrothrombocytopenia. Another mutation described at the same codon (208) has been found to be associated with thrombocytopenia only. Our data support and extend the effect of the amino acid substitution at codon 208 on GATA-1 function not only regarding megakaryocyte but also regarding erythroid development. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103636     DOI: 10.1159/000086586

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  24 in total

1.  Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.

Authors:  Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Journal:  Ann Hematol       Date:  2010-10-05       Impact factor: 3.673

2.  Analysis of disease-causing GATA1 mutations in murine gene complementation systems.

Authors:  Amy E Campbell; Lorna Wilkinson-White; Joel P Mackay; Jacqueline M Matthews; Gerd A Blobel
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

Review 3.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

4.  GATA1 erythroid-specific regulation of SEC23B expression and its implication in the pathogenesis of congenital dyserythropoietic anemia type II.

Authors:  Roberta Russo; Immacolata Andolfo; Antonella Gambale; Gianluca De Rosa; Francesco Manna; Alessandra Arillo; Farooq Wandroo; Maria Grazia Bisconte; Achille Iolascon
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

5.  The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.

Authors:  Mark Minie; Stuart Bowers; Peter Tarczy-Hornoch; Edward Roberts; Rose A James; Neil Rambo; Sherrilynne Fuller
Journal:  J Med Libr Assoc       Date:  2006-07

6.  Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature.

Authors:  Bhavya S Doshi; Carlos Abramowsky; Michael Briones; Silvia T Bunting
Journal:  Am J Blood Res       Date:  2014-09-05

7.  Current Strategies in Diagnosis of Inherited Storage Pool Defects.

Authors:  Kirstin Sandrock; Barbara Zieger
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

Review 8.  Inherited platelet dysfunction and hematopoietic transcription factor mutations.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Platelets       Date:  2016-07-27       Impact factor: 3.862

Review 9.  Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.

Authors:  Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  Exp Hematol       Date:  2016-01-08       Impact factor: 3.084

10.  Human phenotypes associated with GATA-1 mutations.

Authors:  Wendy A Ciovacco; Wendy H Raskind; Melissa A Kacena
Journal:  Gene       Date:  2008-09-30       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.